Advance Care Planning for Black and White Older Adults With Serious Illness
Source: View publication →
In a cluster randomized trial of older adults with serious illness, a facilitated advance care planning intervention was not significantly more effective than a self-guided approach within Black or White subgroups, though an interaction effect suggested the facilitated approach was relatively more effective for Black participants compared to White participants.
Key Findings
Study Design
Study Limitations
Clinical Significance
The EQUAL ACP trial demonstrates that structured advance care planning interventions can achieve high completion rates (nearly 70%) among both Black and White older adults with serious illness. Although a facilitated approach did not outright beat a self-guided approach within either racial subgroup independently, the significant racial interaction indicates that Black patients may derive greater relative benefit from facilitated ACP than White patients. This highlights the clinical importance of tailoring ACP delivery strategies to demographic groups to maximize engagement and help bridge known racial disparities in end-of-life care planning.
Historical Context
Historically, Black adults in the United States have had significantly lower rates of advance care planning (ACP) participation compared to White adults. This disparity has contributed to well-documented differences in end-of-life care, including lower utilization of hospice services and higher rates of aggressive, often non-beneficial, interventions at the end of life. Previous ACP interventions have largely been applied universally without examining their differential effectiveness across racial lines. The EQUAL ACP trial (NCT03516994) was specifically designed to evaluate whether a culturally sensitive, facilitated ACP approach could better overcome these barriers compared to a standard self-guided approach, and to rigorously test the impact of racial concordance between facilitators and patients.
Guided Discussion
High-yield insights from every perspective
What are the foundational components of advance care planning (ACP), and what historical and sociocultural factors might contribute to differences in how Black and White older adults engage with self-guided versus facilitated ACP interventions?
Key Response
ACP involves identifying a surrogate decision-maker and articulating values for end-of-life care. Students must understand that medical mistrust stemming from historical injustices, differing spiritual beliefs regarding end-of-life, and systemic healthcare inequities heavily influence ACP engagement. These factors explain why simply providing self-guided materials may be insufficient, making culturally sensitive, relationship-based facilitated approaches critical for certain populations.
Given the study's finding that facilitated advance care planning showed a relatively greater impact on Black patients compared to self-guided methods, how should this influence your approach to goals-of-care conversations when admitting a Black older adult with a serious illness?
Key Response
Residents should recognize that merely providing a standardized form or pamphlet is often inadequate for meaningful ACP. Taking the time for a facilitated, relationship-based discussion to explore patient values, address potential mistrust, and clarify medical information is an essential clinical skill, especially for populations that experience higher baseline systemic barriers to healthcare engagement.
The study identified a significant interaction effect suggesting facilitated ACP is relatively more beneficial for Black patients compared to White patients, despite null findings within the isolated subgroups. In the context of a palliative care consult service, how do you interpret this differential treatment response, and how might it influence resource allocation for ACP navigators?
Key Response
Fellows must grapple with heterogeneous treatment effects. The interaction suggests that White patients might reach a 'ceiling effect' with self-guided tools due to higher baseline health literacy or systemic trust, whereas Black patients specifically benefit from the relational aspect of facilitated ACP. This justifies directing scarce navigator and social work resources toward populations facing structural barriers, maximizing the impact of the intervention.
As a clinic director implementing an ACP program, how does the interaction effect demonstrated in this trial justify a targeted, equity-focused approach to patient outreach rather than a universal 'one-size-fits-all' model?
Key Response
Attendings must make system-level workflow decisions. Universal interventions often inadvertently widen disparities if advantaged groups utilize them more effectively. This study supports 'targeted universalism' or equity-focused resource allocation, demonstrating that intensive, facilitated models yield a relatively higher return on investment for minoritized populations who are less served by default, low-resource self-guided materials.
Scholarly Review
Critical appraisal through the lens of expert reviewers and guideline development
In a cluster randomized trial where main subgroup effects are non-significant but the interaction term (Intervention x Race) is significant, what are the methodological challenges regarding statistical power and intracluster correlation coefficient (ICC) estimation, and how should future trials be powered to definitively test these subgroup interactions?
Key Response
Interaction tests are notoriously underpowered in clinical trials. A significant interaction despite null subgroup main effects suggests the study was likely only powered for the overall cohort main effect. PhD researchers must account for the ICC within clinics or providers when calculating sample sizes for interaction effects, which often requires exponentially larger sample sizes to avoid Type II errors in subgroup analyses.
When reviewing a manuscript claiming a significant interaction effect by race in a cluster-randomized trial, what critical confounders related to clinic-level characteristics (e.g., clinic resources, geographic location, patient socioeconomic status) must be scrutinized to ensure the interaction is driven by patient demographics rather than the specific clusters to which they belong?
Key Response
Editors must look out for ecological fallacies or confounding by cluster. If Black participants were disproportionately clustered in under-resourced clinics where self-guided tools failed universally due to lack of staff follow-up, the interaction might reflect clinic-level structural disparities rather than racial differences in response to facilitation. Thoroughly controlling for cluster-level covariates is essential for the validity of the interaction claim.
Current guidelines broadly recommend ACP for all older adults with serious illness but rarely specify the delivery modality based on patient demographics. Does the evidence of a differential racial response to facilitated versus self-guided ACP warrant an update to geriatric and palliative care guidelines to explicitly recommend equity-tailored ACP pathways?
Key Response
Guideline committees must weigh whether a secondary interaction effect in one trial is sufficient to change broad practice guidelines. While current guidelines emphasize universal ACP, this trial suggests a need for equity-tailored pathways. The committee might consider issuing a moderate recommendation to prioritize high-touch, facilitated ACP modalities for populations with known historical disparities, moving away from a uniform standard of care that relies on self-guided advance directives.
Clinical Landscape
Noteworthy Related Trials
SUPPORT Trial
Tested
Nurse-mediated communication to improve end-of-life care
Population
Hospitalized patients with life-threatening illnesses
Comparator
Usual care
Endpoint
Incidence of do-not-resuscitate (DNR) orders and physician knowledge of patient preferences
Early Palliative Care in NSCLC Trial
Tested
Early integration of palliative care alongside standard oncology care
Population
Patients with newly diagnosed metastatic non-small-cell lung cancer
Comparator
Standard oncology care alone
Endpoint
Change in quality of life at 12 weeks
PREPARE for Your Care Trial
Tested
Interactive PREPARE website plus easy-to-read advance directive
Population
Diverse older adults with serious chronic illness
Comparator
Easy-to-read advance directive alone
Endpoint
New advance care planning documentation
Tailored to your role
Want this tailored to you?
Add your specialty or training stage to get role-specific takeaways and more questions.
Personalize this analysis